Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Giant Cell Arteritis

tetradecanoylphorbol acetate has been researched along with Giant Cell Arteritis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessandro, R; Belloni, L; Boiardi, L; Bonacini, M; Cavazza, A; Ciccia, F; Cimino, L; Croci, S; Moramarco, A; Muratore, F; Parmeggiani, M; Rizzo, A; Salvarani, C; Zerbini, A1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Giant Cell Arteritis

ArticleYear
Increased expression of interleukin-22 in patients with giant cell arteritis.
    Rheumatology (Oxford, England), 2018, 01-01, Volume: 57, Issue:1

    Topics: Aged; Aged, 80 and over; Calcium Ionophores; Carcinogens; Case-Control Studies; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Giant Cell Arteritis; Humans; Immunohistochemistry; In Vitro Techniques; Interleukin-22; Interleukins; Ionomycin; Leukocytes, Mononuclear; Male; Real-Time Polymerase Chain Reaction; RNA, Messenger; Temporal Arteries; Tetradecanoylphorbol Acetate

2018